Migraine with Aura: What It Looks Like, What Causes It, and When to Worry

Migraine with aura produces temporary neurological symptoms, most often shimmering zigzag lines, a growing blind spot, or spreading numbness, that build gradually over 5 to 60 minutes before or during a migraine headache. It affects roughly 25 to 30 percent of people who have migraine, is driven by a slow wave of brain activity called cortical spreading depression, and only rarely signals a medical emergency.

What Migraine Aura Actually Looks Like

Migraine aura is a transient neurological disturbance that typically precedes the headache phase. The International Headache Society classifies it as fully reversible visual, sensory, speech, motor, brainstem, or retinal symptoms that develop gradually over at least 5 minutes and last no longer than 60 minutes [1].

Migraine aura is sometimes called classic migraine or migraine with neurological symptoms, and it is one subtype within the broader condition of migraine, which also includes migraine without aura, chronic migraine, and vestibular migraine.

The gradual onset is key. Unlike a stroke, where symptoms appear suddenly, aura builds slowly as the cortical spreading depression wave moves across the brain at approximately 3-5 mm per minute.

Visual Aura (Most Common: 90% of Aura Cases)

The classic visual aura follows a predictable pattern:

• Scintillating scotoma: A small blind spot near the center of vision that expands outward over 5-20 minutes, leaving a crescent-shaped zone of visual loss bordered by shimmering, zigzag lines (fortification spectra)
• Photopsia: Flashing or flickering lights, often described as sparkles or lightning bolts
• Visual field distortion: Blurring, tunnel vision, or kaleidoscope-like fragmentation of visual images
• Negative symptoms: Partial or complete loss of vision in one area of the visual field (hemianopia)

Visual aura affects both eyes simultaneously because it originates in the visual cortex, not the retina. This distinguishes it from retinal migraine, which affects one eye only [2].

Patients often use the term ocular migraine loosely to describe these visual symptoms, though clinicians reserve that label for a narrower set of presentations and use retinal migraine specifically for the one eyed form described above.

Sensory Aura (Second Most Common)

Tingling or numbness that starts in the fingers of one hand, spreads up the arm, and may reach the face and tongue on the same side. This “march” of sensory symptoms mirrors the cortical spreading depression wave moving across the somatosensory cortex. It occurs in approximately 31% of people who experience aura [3].

Speech and Language Aura

Difficulty finding words (dysphasic aura) occurs in about 18% of aura episodes. Patients describe knowing what they want to say but being unable to form the words, or producing jumbled speech. This resolves completely as the aura passes.

Motor Aura (Hemiplegic Migraine)

Temporary weakness on one side of the body. This is classified separately as hemiplegic migraine and is the most concerning form of aura because it closely mimics stroke. It may be familial (linked to specific calcium channel, sodium channel, or sodium-potassium pump mutations) or sporadic. Motor aura can last longer than other aura types, sometimes persisting for hours to days [4].

How Is Migraine Aura Diagnosed?

Migraine aura is diagnosed clinically using the criteria in the International Classification of Headache Disorders, 3rd edition (ICHD-3): at least two attacks with one or more fully reversible aura symptoms that develop gradually over 5 minutes or more and last 5 to 60 minutes each, typically followed by headache within 60 minutes [1]. No blood test or imaging finding confirms the diagnosis on its own.

A neurologist or primary care clinician typically takes a detailed history of the aura's onset, march, and duration, since the gradual, evolving pattern is what separates migraine aura from a vascular event. Brain MRI or CT is reserved for atypical presentations: a first episode of motor weakness, aura that does not resolve, onset after age 40, or any feature listed in the emergency section below.

Keeping a symptom log that notes how each episode started, which body part was affected first, and how long it lasted helps a clinician apply the ICHD-3 criteria accurately and distinguish migraine aura from transient ischemic attack, ocular migraine, or a routine case of migraine versus a standard headache.

The Biology: Cortical Spreading Depression

Migraine aura is caused by cortical spreading depression (CSD), a wave of intense neuronal and glial depolarization that spreads across the cerebral cortex at 2-6 mm per minute, followed by a prolonged period of neuronal suppression [5].

During CSD:

1. Neurons in the affected cortical area fire massively (positive symptoms: flashing lights, tingling)
2. This is followed by neuronal silencing (negative symptoms: blind spots, numbness)
3. The wave propagates outward from the initiation point, which is why symptoms appear to “spread” or “march” across the visual field or body
4. Local blood flow changes accompany the wave: brief hyperemia (increased flow) during depolarization, followed by oligemia (decreased flow) during suppression

CSD also activates trigeminal nerve fibers and triggers the release of CGRP (calcitonin gene-related peptide), which drives the subsequent headache phase. This is why CGRP-targeting medications (gepants, anti-CGRP antibodies) are effective for preventing and treating migraine with aura [6].

Aura Without Headache

Approximately 4% of aura episodes occur without any subsequent headache. This is called “migraine aura without headache” or, colloquially, “silent migraine.” It becomes more common with age: many people who had migraine with aura in their 20s-30s develop aura-only episodes in their 50s-60s as the headache component fades [7].

Aura without headache can be difficult to distinguish from transient ischemic attack (TIA), particularly in older adults or those with cardiovascular risk factors. The gradual onset (over minutes) versus sudden onset (seconds) is the most reliable clinical differentiator, but imaging may be warranted for new-onset aura without headache over age 40.

Triggers Specific to Aura

While standard migraine triggers (stress, sleep disruption, hormonal fluctuations, weather changes) apply to migraine with aura, some triggers appear more specifically associated with aura onset:

• Intense visual stimulation: Flickering lights, high-contrast patterns, prolonged screen use
• Physical exertion: Exercise-triggered aura is documented, possibly through changes in cerebral blood flow
• Caffeine withdrawal: Abrupt cessation after regular use can trigger both aura and headache
• Specific foods: Aged cheeses, wine, and tyramine-containing foods are reported aura triggers, though individual variation is high
• Hormonal shifts: Estrogen withdrawal during menstruation is a documented aura trigger. This has implications for oral contraceptive use (see below)

A structured migraine diet approach, built around identifying and removing individual trigger foods rather than broad elimination, is one practical way to track these patterns over several weeks.

Migraine with Aura and Stroke Risk

Migraine with aura carries a modestly elevated stroke risk compared to both migraine without aura and the general population. A meta-analysis in the BMJ found a relative risk of 2.16 for ischemic stroke in women with migraine with aura [8].

In absolute terms, the risk remains small: approximately 4 additional strokes per 100,000 women per year attributable to migraine with aura. However, the risk compounds with other factors:

• Combined oral contraceptives (COCs): Estrogen-containing birth control increases stroke risk in women with aura. Current guidelines from the WHO and ACOG classify COCs as contraindicated (Category 4) in women with migraine with aura [9]. Progestin-only methods are safe.
• Smoking: Further amplifies the stroke risk. The combination of migraine with aura + smoking + COC use is particularly high-risk.
• Hypertension, diabetes, obesity: Each adds incremental stroke risk.

For men with migraine with aura, stroke risk is also elevated but less studied. Cardiovascular risk factor management is recommended regardless of sex.

When Aura Is an Emergency

Most migraine aura is benign and self-resolving. Seek emergency evaluation if:

• Sudden onset: Symptoms appear at maximum intensity within seconds (suggests vascular event, not CSD)
• Duration beyond 60 minutes: Aura lasting more than an hour may indicate persistent focal neurological deficit
• Motor weakness: First episode of weakness warrants imaging to exclude stroke
• New pattern after age 40: New-onset aura in middle age or beyond requires investigation
• Accompanied by fever, stiff neck, or altered consciousness: Suggests CNS infection or hemorrhage
• Vision loss in one eye only: May indicate retinal migraine or retinal vascular event

Treatment: Preventing and Managing Aura

Acute Treatment

There is no specific acute treatment for the aura phase itself. Triptans, gepants, and NSAIDs can be taken during aura to reduce the severity of the subsequent headache, though some guidelines recommend waiting until the headache begins [1]. The medication options for migraine overlap heavily with standard migraine care, since aura itself has no dedicated acute drug class of its own.

Magnesium may abort aura: a pilot study found that 400 mg of oral magnesium citrate taken at aura onset shortened aura duration in some patients. This is based on magnesium’s role in modulating cortical excitability and suppressing CSD.

Preventive Treatment

If aura occurs frequently (more than 4 episodes/month or significantly impacts quality of life), preventive therapy is warranted:

• Anti-CGRP monoclonal antibodies (erenumab, fremanezumab, galcanezumab): Effective for both migraine with and without aura. Monthly or quarterly injections.
• Topiramate: Reduces aura frequency through sodium channel blockade and glutamate modulation. The most evidence-based preventive specifically studied in migraine with aura.
• Lamotrigine: Limited evidence but some specialists use it for aura-predominant migraine based on its ability to block CSD. May be particularly useful for patients with frequent aura but infrequent headache [10].
• Magnesium supplementation: 400-600 mg daily of magnesium glycinate or citrate. Reduces cortical excitability and has a favorable safety profile.
• Riboflavin (vitamin B2): 400 mg daily has shown migraine-preventive effects in clinical trials, likely through mitochondrial energy metabolism support.

Because preventive choices depend on aura frequency, cardiovascular risk factors, and whether headache accompanies the aura, many patients work out a formal plan with a headache specialist or a functional medicine clinician. The migraine treatment guide on this site walks through how these medication classes compare in more detail, and the national directory of migraine treatment clinics lists verified practices by location. Listing order in that directory is not paid ranking, and inclusion is not an endorsement of any single clinic.

Living with Migraine Aura

Practical strategies for managing aura episodes:

• Keep a detailed trigger diary (including visual stimuli, sleep, stress, and hormonal patterns)
• If driving when aura begins, pull over immediately. Visual aura impairs safe driving.
• Inform colleagues and family about aura so they understand when you need to step away
• Consider wearing FL-41 tinted glasses, which filter the light wavelengths most likely to trigger CSD
• Maintain consistent sleep, hydration, and meal schedules to reduce cortical excitability
• Review day-of-attack strategies in our guide to migraine relief techniques, which can be used alongside the aura-specific precautions above

Frequently Asked Questions

What does migraine aura feel like?

Migraine aura most often feels like shimmering zigzag lines or a growing blind spot in the vision, tingling that spreads from the fingers up one arm, or brief trouble finding words. Symptoms build gradually over several minutes, unlike the sudden onset of a stroke, and resolve completely within 60 minutes in most cases, typically followed by a headache.

Can you have migraine aura without a headache?

Yes. About 4 percent of aura episodes occur with no headache at all, a pattern sometimes called silent migraine, and it becomes more common after age 50 as the headache component of migraine fades with age [7]. Because it can resemble a transient ischemic attack, new onset aura without headache after age 40 usually warrants evaluation.

Is migraine with aura dangerous?

Most migraine aura is benign and resolves on its own. It does carry a modestly higher ischemic stroke risk, particularly in women who also smoke or use combined oral contraceptives, with a relative risk near 2.16 reported in a BMJ meta-analysis [8]. Sudden onset symptoms, motor weakness, or aura lasting beyond 60 minutes should be evaluated urgently.

What triggers migraine aura specifically?

Flickering or high contrast light, intense physical exertion, caffeine withdrawal, certain foods such as aged cheese or wine, and estrogen withdrawal around menstruation are the triggers most often linked to aura onset specifically, in addition to the stress and sleep disruption that trigger migraine generally. Individual patterns vary, which is why a trigger diary is useful.

How long does migraine aura usually last?

By definition, migraine aura develops gradually over at least 5 minutes and resolves within 60 minutes, with most episodes lasting 20 to 30 minutes [2]. Aura that persists longer than an hour, or motor weakness that lasts longer, falls outside typical migraine aura and should prompt medical evaluation to rule out a vascular cause.

Can migraine aura be prevented?

Frequent aura can be reduced with preventive medications such as topiramate, which carries the most aura specific evidence, lamotrigine, anti-CGRP monoclonal antibodies, and supplements including magnesium and riboflavin [10]. None of these options eliminate aura for everyone, and evidence for some, particularly supplements, remains more limited than for prescription preventives.

Related Reading

• Migraine: The Evidence-Based Guide (Pillar)
• Migraine Treatment: Medications, Preventives, and Regenerative Options
• Vestibular Migraine: The Dizziness-Migraine Connection

Sources

1. Headache Classification Committee of the International Headache Society. The International Classification of Headache Disorders, 3rd edition. Cephalalgia. 2018;38(1):1-211. doi:10.1177/0333102417738202 ↩
2. Viana M, Sprenger T, Andelova M, et al. The typical duration of migraine aura: a systematic review. Cephalalgia. 2013;33(7):483-490. doi:10.1177/0333102413479833 ↩
3. Russell MB, Olesen J. A nosographic analysis of the migraine aura in a general population. Brain. 1996;119(Pt 2):355-361. doi:10.1093/brain/119.2.355 ↩
4. Russell MB, Ducros A. Sporadic and familial hemiplegic migraine: pathophysiological mechanisms, clinical characteristics, diagnosis, and management. Lancet Neurol. 2011;10(5):457-470. doi:10.1016/S1474-4422(11)70048-5 ↩
5. Lauritzen M. Pathophysiology of the migraine aura: the spreading depression theory. Brain. 1994;117(Pt 1):199-210. doi:10.1093/brain/117.1.199 ↩
6. Goadsby PJ, Edvinsson L, Ekman R. Vasoactive peptide release in the extracerebral circulation of humans during migraine headache. Ann Neurol. 1990;28(2):183-187. doi:10.1002/ana.410280213 ↩
7. Wijman CA, Wolf PA, Kase CS, et al. Migrainous visual accompaniments are not rare in late life: the Framingham Study. Stroke. 1998;29(8):1539-1543. doi:10.1161/01.STR.29.8.1539 ↩
8. Schurks M, Rist PM, Bigal ME, et al. Migraine and cardiovascular disease: systematic review and meta-analysis. BMJ. 2009;339:b3914. doi:10.1136/bmj.b3914 ↩
9. MacGregor EA. Contraception and headache. Headache. 2013;53(2):247-276. doi:10.1111/head.12035 ↩
10. Lampl C, Katsarava Z, Diener HC, et al. Lamotrigine reduces migraine aura and migraine attacks in patients with migraine with aura. J Neurol Neurosurg Psychiatry. 2005;76(12):1730-1732. doi:10.1136/jnnp.2005.063750 ↩